Diclofenac-Darnitsa
Nonsteroidal anti-inflammatory and antirheumatic drugs. Acetic acid derivatives and related compounds
Release form:
Diclofenac-Darnitsa contains diclofenac sodium, a nonsteroidal anti-inflammatory drug with pronounced antirheumatic, anti-inflammatory, analgesic, and antipyretic properties. Inhibiting the biosynthesis of prostaglandins, which play a crucial role in the genesis of inflammation, pain, and fever, is believed to be the main mechanism of action of the drug.
Intramuscular injections of the drug are intended for treatment of:
– Inflammatory and degenerative forms of rheumatism, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylarthritis, vertebral pain syndrome, soft tissue rheumatism
– Acute gout attacks
– Renal and biliary colic
– Pain and edema after injuries and surgeries
– Severe migraine attacks
Intravenous infusions of the drug are intended for the treatment or prevention of postoperative pain.
The drug should be used in the smallest recommended doses for the shortest possible time, considering the individual treatment goal in every case.
Diclofenac-Darnitsa, solution for injection, should not be used for longer than 2 days. If necessary, treatment can be extended using Diclofenac-Darnitsa tablets.
Children.
Diclofenac-Darnitsa as solution for injection is contraindicated in children.